O	0	10	Systematic	Systematic	JJ	B-NP
O	11	20	proteomic	proteomic	JJ	I-NP
O	21	29	analysis	analysis	NN	I-NP
O	30	32	of	of	IN	B-PP
O	33	38	human	human	JJ	B-NP
B-Cell	39	53	hepotacellular	hepotacellular	JJ	I-NP
I-Cell	54	63	carcinoma	carcinoma	NN	I-NP
I-Cell	64	69	cells	cell	NNS	I-NP
O	70	77	reveals	reveal	VBZ	B-VP
O	78	87	molecular	molecular	JJ	B-NP
O	88	96	pathways	pathway	NNS	I-NP
O	97	100	and	and	CC	I-NP
O	101	109	networks	network	NNS	I-NP
O	110	118	involved	involve	VBN	B-VP
O	119	121	in	in	IN	B-PP
O	122	132	metastasis	metastasis	NN	B-NP
O	132	133	.	.	.	O

O	135	145	Systematic	Systematic	JJ	B-NP
O	146	155	proteomic	proteomic	JJ	I-NP
O	156	164	studying	studying	NN	I-NP
O	165	167	of	of	IN	B-PP
O	168	171	the	the	DT	B-NP
O	172	181	mechanism	mechanism	NN	I-NP
O	182	184	of	of	IN	B-PP
B-Cancer	185	199	hepatocellular	hepatocellular	JJ	B-NP
I-Cancer	200	209	carcinoma	carcinoma	NN	I-NP
O	210	211	(	(	(	O
B-Cancer	211	214	HCC	HCC	NN	B-NP
O	214	215	)	)	)	O
O	216	226	metastasis	metastasis	NN	B-NP
O	227	234	remains	remain	VBZ	B-VP
O	235	246	challenging	challenging	JJ	B-ADJP
O	246	247	.	.	.	O

O	248	250	We	We	PRP	B-NP
O	251	260	performed	perform	VBD	B-VP
O	261	272	comparative	comparative	JJ	B-NP
O	273	282	proteomic	proteomic	JJ	I-NP
O	283	286	and	and	CC	I-NP
O	287	294	pathway	pathway	NN	I-NP
O	295	303	analysis	analysis	NN	I-NP
O	304	306	of	of	IN	B-PP
O	307	311	four	four	CD	B-NP
O	312	317	human	human	JJ	I-NP
B-Cell	318	328	metastatic	metastatic	JJ	I-NP
I-Cell	329	332	HCC	HCC	NN	I-NP
I-Cell	333	337	cell	cell	NN	I-NP
I-Cell	338	343	lines	line	NNS	I-NP
O	344	346	to	to	TO	B-VP
O	347	355	identify	identify	VB	I-VP
O	356	366	metastasis	metastasis	NN	B-NP
O	366	367	-	-	HYPH	B-NP
O	367	377	associated	associate	VBN	I-NP
O	378	386	proteins	protein	NNS	I-NP
O	386	387	.	.	.	O

O	388	393	These	These	DT	B-NP
B-Cell	394	397	HCC	HCC	NN	I-NP
I-Cell	398	402	cell	cell	NN	I-NP
I-Cell	403	408	lines	line	NNS	I-NP
O	409	412	had	have	VBD	B-VP
O	413	414	a	a	DT	B-NP
O	415	422	similar	similar	JJ	I-NP
O	423	430	genetic	genetic	JJ	I-NP
O	431	441	background	background	NN	I-NP
O	442	445	but	but	CC	B-PP
O	446	450	with	with	IN	B-PP
O	451	453	an	an	DT	B-NP
O	454	464	increasing	increase	VBG	I-NP
O	465	474	potential	potential	NN	I-NP
O	475	477	of	of	IN	B-PP
O	478	488	metastasis	metastasis	NN	B-NP
O	488	489	.	.	.	O

O	490	495	Using	Use	VBG	B-VP
O	496	497	a	a	DT	B-NP
O	498	509	combination	combination	NN	I-NP
O	510	512	of	of	IN	B-PP
O	513	516	two	two	CD	B-NP
O	517	528	dimensional	dimensional	JJ	I-NP
O	529	544	electrophoresis	electrophoresis	NN	I-NP
O	545	546	(	(	(	O
O	546	547	2	2	CD	B-NP
O	547	548	-	-	HYPH	I-NP
O	548	550	DE	DE	NN	I-NP
O	550	551	)	)	)	O
O	552	555	and	and	CC	O
O	556	561	MALDI	MALDI	NN	B-NP
O	561	562	-	-	HYPH	I-NP
O	562	565	TOF	TOF	NN	I-NP
O	566	570	mass	mass	NN	I-NP
O	571	583	spectrometry	spectrometry	NN	I-NP
O	583	584	,	,	,	O
O	585	586	a	a	DT	B-NP
O	587	592	total	total	NN	I-NP
O	593	595	of	of	IN	B-PP
O	596	599	125	125	CD	B-NP
O	600	608	proteins	protein	NNS	I-NP
O	609	612	and	and	CC	O
O	613	618	their	their	PRP$	B-NP
O	619	623	post	post	AFX	I-NP
O	623	624	-	-	HYPH	I-NP
O	624	637	translational	translational	JJ	I-NP
O	638	650	modification	modification	NN	I-NP
O	651	656	forms	form	NNS	I-NP
O	657	659	or	or	CC	I-NP
O	660	668	isoforms	isoform	NNS	I-NP
O	669	673	were	be	VBD	B-VP
O	674	679	found	find	VBN	I-VP
O	680	682	to	to	TO	I-VP
O	683	685	be	be	VB	I-VP
O	686	700	differentially	differentially	RB	I-VP
O	701	710	expressed	express	VBN	I-VP
O	711	713	in	in	IN	B-PP
O	714	717	the	the	DT	B-NP
B-Cell	718	722	cell	cell	NN	I-NP
I-Cell	723	728	lines	line	NNS	I-NP
O	728	729	.	.	.	O

O	730	735	Among	Among	IN	B-PP
O	736	740	them	them	PRP	B-NP
O	740	741	,	,	,	O
O	742	744	29	29	CD	B-NP
O	745	749	were	be	VBD	B-VP
O	750	759	gradually	gradually	RB	B-ADVP
O	760	762	up	up	RB	B-ADVP
O	762	763	-	-	HYPH	B-NP
O	763	772	regulated	regulate	VBN	B-VP
O	773	780	whereas	whereas	IN	B-PP
O	781	783	17	17	CD	B-NP
O	784	788	were	be	VBD	B-VP
O	789	793	down	down	RB	B-ADVP
O	793	794	-	-	HYPH	B-NP
O	794	803	regulated	regulate	VBN	B-VP
O	804	808	with	with	IN	B-PP
O	809	819	increasing	increase	VBG	B-NP
O	820	830	metastatic	metastatic	JJ	I-NP
O	831	840	potential	potential	NN	I-NP
O	840	841	.	.	.	O

O	842	849	Instead	Instead	RB	B-PP
O	850	852	of	of	IN	I-PP
O	853	854	a	a	DT	B-NP
O	855	866	traditional	traditional	JJ	I-NP
O	867	873	single	single	JJ	I-NP
O	873	874	-	-	HYPH	I-NP
O	874	878	gene	gene	NN	I-NP
O	879	886	readout	readout	NN	I-NP
O	886	887	,	,	,	O
O	888	894	global	global	JJ	B-NP
O	895	909	bioinformatics	bioinformatic	NNS	I-NP
O	910	918	analysis	analysis	NN	I-NP
O	919	922	was	be	VBD	B-VP
O	923	930	carried	carry	VBN	I-VP
O	931	934	out	out	RP	B-PRT
O	934	935	,	,	,	O
O	936	941	which	which	WDT	B-NP
O	942	950	revealed	reveal	VBD	B-VP
O	951	955	that	that	IN	B-SBAR
O	956	959	the	the	DT	B-NP
O	960	970	glycolysis	glycolysis	NN	I-NP
O	971	978	pathway	pathway	NN	I-NP
O	979	982	was	be	VBD	B-VP
O	983	986	the	the	DT	B-NP
O	987	991	most	most	RBS	I-NP
O	992	1005	significantly	significantly	RB	I-NP
O	1006	1014	enriched	enrich	VBN	I-NP
O	1015	1022	pathway	pathway	NN	I-NP
O	1022	1023	.	.	.	O

O	1024	1027	The	The	DT	B-NP
O	1028	1032	heat	heat	NN	I-NP
O	1033	1038	shock	shock	NN	I-NP
O	1039	1047	proteins	protein	NNS	I-NP
O	1048	1049	(	(	(	O
O	1049	1053	HSPs	HSP	NNS	B-NP
O	1053	1054	)	)	)	O
O	1055	1063	centered	centered	JJ	B-NP
O	1064	1067	and	and	CC	I-NP
O	1068	1070	NF	NF	NN	I-NP
O	1070	1071	-	-	HYPH	I-NP
O	1071	1077	kappaB	kappaB	NN	I-NP
O	1078	1086	centered	centered	JJ	I-NP
O	1087	1095	networks	network	NNS	I-NP
O	1096	1100	were	be	VBD	B-VP
O	1101	1105	also	also	RB	I-VP
O	1106	1114	enriched	enrich	VBN	I-VP
O	1115	1117	in	in	IN	B-PP
O	1118	1121	the	the	DT	B-NP
O	1122	1128	result	result	NN	I-NP
O	1128	1129	,	,	,	O
O	1130	1135	which	which	WDT	B-NP
O	1136	1139	may	may	MD	B-VP
O	1140	1145	imply	imply	VB	I-VP
O	1146	1149	the	the	DT	B-NP
O	1150	1153	key	key	JJ	I-NP
O	1154	1162	function	function	NN	I-NP
O	1163	1165	of	of	IN	B-PP
O	1166	1175	inflaming	inflame	VBG	B-VP
O	1176	1178	on	on	IN	B-PP
O	1179	1189	metastasis	metastasis	NN	B-NP
O	1189	1190	.	.	.	O

O	1191	1200	Meanwhile	Meanwhile	RB	B-ADVP
O	1200	1201	,	,	,	O
O	1202	1211	knockdown	knockdown	NN	B-NP
O	1212	1214	of	of	IN	B-PP
O	1215	1219	HDGF	HDGF	NN	B-NP
O	1219	1220	,	,	,	O
O	1221	1223	an	an	DT	B-NP
O	1224	1226	up	up	RB	I-NP
O	1226	1227	-	-	HYPH	I-NP
O	1227	1236	regulated	regulate	VBN	B-NP
O	1237	1244	protein	protein	NN	I-NP
O	1245	1248	and	and	CC	O
O	1249	1250	a	a	DT	B-NP
O	1251	1257	target	target	NN	I-NP
O	1258	1260	of	of	IN	B-PP
O	1261	1263	NF	NF	NN	B-NP
O	1263	1264	-	-	HYPH	B-NP
O	1264	1270	kappaB	kappaB	NN	I-NP
O	1270	1271	,	,	,	O
O	1272	1279	induced	induce	VBD	B-VP
B-Cell	1280	1284	cell	cell	NN	B-NP
O	1285	1294	apoptosis	apoptosis	NN	I-NP
O	1295	1297	in	in	IN	B-PP
O	1298	1301	the	the	DT	B-NP
B-Cell	1302	1312	metastatic	metastatic	JJ	I-NP
I-Cell	1313	1316	HCC	HCC	NN	I-NP
I-Cell	1317	1322	cells	cell	NNS	I-NP
O	1322	1323	.	.	.	O

O	1324	1328	This	This	DT	B-NP
O	1329	1333	work	work	NN	I-NP
O	1334	1342	provides	provide	VBZ	B-VP
O	1343	1344	a	a	DT	B-NP
O	1345	1358	demonstration	demonstration	NN	I-NP
O	1359	1363	that	that	IN	B-SBAR
O	1364	1365	a	a	DT	B-NP
O	1366	1377	combination	combination	NN	I-NP
O	1378	1380	of	of	IN	B-PP
O	1381	1395	bioinformatics	bioinformatic	NNS	B-NP
O	1396	1399	and	and	CC	O
O	1400	1411	comparative	comparative	JJ	B-NP
O	1412	1422	proteomics	proteomic	NNS	I-NP
O	1423	1426	can	can	MD	B-VP
O	1427	1431	help	help	VB	I-VP
O	1432	1434	in	in	IN	B-PP
O	1435	1442	finding	find	VBG	B-VP
O	1443	1446	out	out	RP	B-PRT
O	1447	1456	potential	potential	JJ	B-NP
O	1457	1467	biomarkers	biomarker	NNS	I-NP
O	1468	1478	associated	associate	VBN	B-VP
O	1479	1483	with	with	IN	B-PP
B-Cancer	1484	1487	HCC	HCC	NN	B-NP
O	1488	1498	metastasis	metastasis	NN	I-NP
O	1499	1501	on	on	IN	B-PP
O	1502	1505	the	the	DT	B-NP
O	1506	1511	level	level	NN	I-NP
O	1512	1514	of	of	IN	B-PP
O	1515	1523	pathways	pathway	NNS	B-NP
O	1523	1524	.	.	.	O

